* Tabula Rasa HealthCare Inc TRHC.OQ TRHC.O is expected
to show a fall in quarterly revenue when it reports results on
November 3.
* The Moorestown New Jersey-based company is expected to
report
a 14.5% decrease in revenue to $74.017 million from $86.59
million a year ago, according to the mean estimate from 6
analysts, based on Refinitiv data. The company's guidance on
August 5 2022, for the period ended September 30, was for
revenue of $96.976 million.
* Refinitiv's mean analyst estimate for Tabula Rasa
HealthCare
Inc is for a loss of 11 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 4
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Tabula Rasa
HealthCare Inc is $6, above its last closing price of $3.91.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Jun. 30 2022 -0.17 -0.12 -0.25 Missed -111.9
Mar. 31 2022 -0.16 -0.16 -0.22 Missed -40
Dec. 31 2021 -0.09 -0.08 -0.09 Missed -14.3
Sep. 30 2021 0.02 0.03 -0.04 Missed -218.5
Jun. 0.00 0.00 -0.01 Missed -200.3
30 2021
Mar. 31 2021 -0.09 -0.09 -0.09 Met 2.4
Dec. 31 2020 -0.10 -0.10 -0.08 Beat 17.2
Sep. 30 2020 0.05 0.04 -0.01 Missed -123.9
This summary was machine generated November 2 at 02:03 GMT. All
figures in US dollars unless otherwise stated